{"text": "2. HORIZON                                                                                                                                                                                      \ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\ufffd\r\n                                                                                                                                                                                     Thursday March 26, 2009\r\n     RESEARCH                                   MEDICINE\r\nDiarrhoea                               Why tough TB bug is on the rise\r\nvaccine                                 The heavy drug burden on co-infected patients is the main cause of untreatable strains and now\r\ntrials on                               physicians are concerned as to which disease condition to treat \ufb01rst, writes DAVID NJAGI\r\nvulnerable depending on access                   been catalysed by inadequate                                                                                              opportunistic infections, although a\r\n                                                 he increase in the number of                                                                                              of indecision when treating HIV\r\n   Page 2 former, especially            T        drug resistant tuberculosis                                                                                               in a double infection case due\r\nin the rural areas, are more                     cases in Kenya could have                                                                                                 to complications occasioned by\r\nto health facilities. Prompt re         research to establish what to treat \ufb01rst                                                                                           combination pill, Combivir, is now\r\nhydration makes the di\ufb00erence           in patients co-infected with HIV/Aids.                                                                                             available.\r\nbetween surviving a bout and               In what is emerging as a problem,                                                                                               Infections\r\nsuccumbing to it. \u201cThere is no          medical experts now say the heavy\r\n                                                                                                                                                                           This, according to Prof. Godfrey Lule,\r\ntreatment for rotavirus, apart          medication prescribed for the two\r\n                                                                                                                                                                           is the basis of an ongoing study at\r\nfrom rehydration which can be           diseases gives most patients a huge\r\n                                                                                                                                                                           the Kenyatta National Hospital to\r\naccessed from hospital,\u201d Dr Feikin      drug burden, pushing some to stop\r\n                                                                                                                                                                           determine the right time to start\r\nsays.                                   taking them prematurely.\r\n                                                                                                                                                                           treatment of the two diseases in\r\n    The mode by which the disease          According to the Division of\r\n                                                                                                                                                                           patients with multiple infections.\r\nspreads remains unknown, but Dr         Leprosy, Tuberculosis and Lung\r\n                                                                                                                                                                               The 18 months old study, says\r\nFeikin said that it was believed to     Diseases in the Ministry of Health\r\n                                                                                                                                                                           Prof. Lule, who also practices at the\r\nspread through contact. Immunity        (DLTLD), putting patients with\r\n                                                                                                                                                                           Nairobi Hospital, is meant to establish\r\nafter infection, he added, is           multiple infections on both HIV and\r\n                                                                                                                                                                           treatment which makes it possible for\r\nincomplete though subsequent            TB prescriptions can indeed stir\r\n                                                                                                                                                                           a multiple infected patient to adhere\r\ninfections are often less severe,       health complications, and has been\r\n                                                                                                                                                                           to simultaneous drug regimens.\r\nhence the need for a vaccine.           the practice in some health centers\r\n                                                                                                                                                                               \u201cThe drug burden is a strong\r\n                                        across the country.\r\nMalnutrition                                                                                                                                                               reason why some multiple infected\r\n                                           According to Dr Joseph Sitenei,\r\nHe said that the vaccine had been                                                                                                                                          patients fail in drug adherence and\r\n                                        director of the DLTLD programme,\r\nlicensed in other countries but                                                                                                                                            could explain the increasing cases of\r\n                                        there is evidence that combined drug\r\nwas yet to be introduced in Africa.                                                                                                                                        TB drug resistance,\u201d says Prof Lule.\r\n                                        prescription for patients su\ufb00ering\r\nAfrica, he noted had unique                                                         the programme pharmacist at DLTLD           Some antiretrovirals available             \u201cThis study is meant to \ufb01nd a solution\r\n                                        from the two conditions can lead to\r\nconditions and it was important                                                     the present mode of treatment for           locally.                                   where these patients can be put on\r\n                                        the development of drug resistant TB\r\nto test it in the continent before                                                  patients with multiple infections           PHOTO / FILE                               simultaneous drug regimens.\u201d\r\n                                        strains.\r\nintroduction. \u201cThere are more                                                       favors TB treatment for the \ufb01rst two                                                       Kenya is ranked 13th on the list of\r\n                                           \u201cWe have evidence that the heavy\r\ncases of malnutrition, poverty,                                                     months, as the patient awaits ARV           on drug adherence, because some of         22 high burden TB countries in the\r\n                                        drug burden shouldered by patients\r\nlack of access to health facilities,                                                therapy later on.                           the treatments are not recommended         world and the \ufb01fth with the highest\r\n                                        leads to low drug adherence,\u201d says\r\namong other factors in Africa,\u201d he                                                                                              on an empty stomach.                       burden in Africa by the World Health\r\n                                        Dr Sitenei. \u201cThis could explain the         XDR-TB\r\nsaid.                                                                                                                                                                      Organisation.\r\n                                                                                                                                   While TB treatment takes at\r\n                                        increasing cases of drug resistant TB       Such has been the dilemma dogging\r\n    Results from the trials, says                                                                                                                                              According to the WHO TB control\r\n                                                                                                                                least six to nine months, if \ufb01rst\r\n                                        that we are witnessing today.\u201d              medics, that adherence to drug\r\nDr Feikin, will be shared with                                                                                                                                             report, Kenya had 140,000 new TB\r\n                                                                                                                                diagnosed, a patient normally starts\r\n                                           Dr Sitienei says the country will        regimen has been cited as one of\r\nrelevant authorities, including the                                                                                                                                        infections in 2008 and an incidence\r\n                                                                                                                                medication with a regimen of four\r\n                                        have to shoulder this burden at the         the reason cases of Multiple Drug\r\nWorld Health Organisation for                                                                                                                                              rate of 153 new cases. Another study\r\n                                                                                                                                drugs, Isoniazid, rifampin (Rifadin),\r\n                                        moment since there are no new drugs         Resistant (MDR) TB have been on\r\napproval.                                                                                                                                                                  conducted by the Centers for Disease\r\n                                                                                                                                ethambutol       (Myambutol)       and\r\n                                        that can reduce the drug burden on          the rise. One case of Extremely\r\n    \u201cThe vaccine trials are                                                                                                                                                Control and Prevention in 2008 says\r\n                                                                                                                                pyrazinamide, but could change if\r\n                                        patients, adding that TB therapy is         Drug Resistant (XDR) TB has been\r\nintended to determine the                                                                                                                                                  cases of MDR TB are underreported\r\n                                                                                                                                tests later show they are ine\ufb00ective.\r\n                                        given priority, since there is evidence     diagnosed in the country so far.\r\ne\ufb03cacy and safety of the vaccine                                                                                                                                           and may actually be prevalent than\r\n                                                                                                                                   At the same time, medics \ufb01nd\r\n                                        that it can kill patients faster than          While this is the case, the persistent\r\nin Kenya,\u201d he said. If approved,                                                                                                                                           previously thought.\r\n                                                                                                                                themselves caught up in a web\r\n                                        HIV. According to Dr Chris Masila,          drought and famine has had its e\ufb00ects\r\nKenyan children could begin\r\nreceiving the vaccine against\r\nrotavirus by 2011. The vaccine\r\nwould be included in the series          AGRICULTURE\r\nof immunization administered to\r\ninfants after birth.\r\n    Dr Feikin said that every child\r\nwould receive a bout of the vaccine\r\nby their third birthday.                Greenhouse tomato farming takes o\ufb00 in Kenya\r\n    \u201cIf the vaccine is e\ufb00ective, this\r\ntrial will help the country decide\r\nwhether to introduce the rotavirus              or farmers constrained by                                                                                                     Potential farmers need not to\r\nvaccine into its expanded               F       small land sizes, the way to                                                                                               worry about the cost of constructing\r\nprogramme on immunization,\u201d he                  go is intensive farming of                                                                                                 simple greenhouses. All they need is\r\nadded.                                          high value crops through                                                                                                   woodwork and recycled greenhouse\r\n    The testing of the rotavirus        technologies such as green housing.                                                                                                polythene sheets, which are readily\r\nvaccine is a joint e\ufb00ort of several        Though the greenhouse tomato                                                                                                    available from large-scale cut \ufb02ower\r\norganisations under the auspices        production is widely practiced around                                                                                              farmers.\r\nof the Rotavirus Vaccine Program        the world, it is relatively a new concept                                                                                            However, the irrigation systems\r\n(RVP) aimed at accelerating the         in Kenyans having been introduced by                                                                                               is standard and the cheapest costs\r\ndevelopment and introduction of         the Horticultural Crops Development                                                                                                Sh7,000 ideal to water 300 plants. The\r\nrotavirus vaccines.                     Authority about three years ago.                                                                                                   cost of simple structures, depending on\r\n    It is a collaboration of CDC,          According to the HCDA o\ufb03cers                                                                                                    size, ranges from Sh38,000 to 130,000.\r\nMerck, and the Program for              in charge of the project, Florence                                                                                                 Mr Polycap Limisi, a retrenched textile\r\nAppropriate Technology in               Masia, and Bartuina Kipyegon, the                                                                                                  worker from Eldoret testi\ufb01es that the\r\nHealth (PATH). The rotavirus            technology creates an ideal tomato                                                                                                 technology is worth a trial.\r\nvaccine trials are aided by the         production environment.\r\nDemographic Surveillance System,           A tomato plant under greenhouse                \u201cThe technology is suitable for       Mr Polycarp Limisi tending to              Satisfactory\r\na population registration system        farming, they say, yields ten times         areas where tomatoes do poorly              tomatoes.\r\nis presently being undertaken by                                                                                                                                           After losing his job at a leading textile\r\n                                        over conventionally farmed crop.            outdoors. It is also suitable for areas     PHOTO / JARED NYATAYA\r\nKEMRI/CDC.                                                                                                                                                                 \ufb01rm in Eldoret about \ufb01ve years ago,\r\n                                        The technology requires low labour          like, Nairobi, Kiambu and Kisii, where\r\n    Karemo Division, the site of                                                                                                                                           Limis \ufb01rst tried his hands on small-\r\n                                        input, and enables farmers to time the      pieces of land are too small,\u201d says Ms      production is that the crop needs little\r\nthe study provides demographic                                                                                                                                             scale maize production.\r\n                                        markets.                                    Masia.                                      water and chemicals while producing\r\nand health information but also                                                                                                                                            But years later, he switched to\r\n                                             \u201cThe HCDA gives free technical            Areas where farmers have                 ten times more than the same number\r\nsampling frames and background                                                                                                                                             greenhouse tomato farming and says\r\n                                        training. We also monitor the projects\u2019     embraced the technology include             of plants grown in the open \ufb01elds.\r\ndata. From the data, diarrhoea has                                                                                                                                         the returns are satisfactory. Limisi\r\n                                        progress to make sure nothing goes          Nyandarua, Machakos, Bungoma,                  One tomato plant producs an\r\nbeen identi\ufb01ed as one of the area\u2019s                                                                                                                                        spent Sh58,000 project.\r\n                                        wrong,\u201d says Charles Ciso, the The          Narok, Bomet and Kitale. \u201cOne great         average of 20 kilogrammes for eight\r\nmajor disease challenges.                                                                                                                                                  \u2014 STEPHEN MBURU AND BARNABAS BII\r\n                                        Narok /Bomet station manager.               advantage of the greenhouse tomato          months,\u201d says Mr Kipyegon.\r\nPage \f\r\n\r\n\r\n-------------------Trial Version-----------------------\r\n\r\nConvert PDF to Text Desktop Software.\r\n\r\nCopyright Convertpdftotext.net 2014.\r\n\r\nTo remove these lines, please activate your software from http://www.convertpdftotext.net/buynow.htm\r\n\r\n-------------------------------------------------------"}